A Phase IIIb Study of Rituximab Maintenance Therapy in Patients with Follicular Non-Hodgkin's Lymphoma Who Have Responded to Induction Therapy - MAXIMA-Protocol.

Blood20.30
Volume: 108, Issue: 11, Pages: 4706 - 4706
Published: Nov 16, 2006
Abstract
null null Five randomized trials (four Phase III and one phase II) have confirmed that rituximab maintenance therapy provides clinical meaningful improvements in terms of Progression Free Survival, Event Free Survival and response duration for patients. Two studies have also found an overall survival advantage for rituximab maintenance therapy (Hoechster et al. 2005, van Oers et al. 2005) and a third study could demonstrate a strong trend...
Paper Details
Title
A Phase IIIb Study of Rituximab Maintenance Therapy in Patients with Follicular Non-Hodgkin's Lymphoma Who Have Responded to Induction Therapy - MAXIMA-Protocol.
Published Date
Nov 16, 2006
Journal
Volume
108
Issue
11
Pages
4706 - 4706
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.